CDC Pauses Dozens of Lab Tests Amid Evaluation

Downsizing and restructuring at the agency has led to the temporary suspension of testing for rabies, monkeypox, and other infectious diseases.

Apr. 12, 2026 at 4:52pm

Got story updates? Submit your updates here. ›

An extreme close-up X-ray photograph revealing the ghostly, glowing structures of infectious disease microbes on a microscope slide, conceptually illustrating the critical role of the CDC's laboratory testing capabilities.The CDC's temporary pause on dozens of infectious disease tests raises concerns about the agency's ability to quickly identify and respond to emerging public health threats.North Port Today

The Centers for Disease Control and Prevention (CDC) has temporarily paused dozens of types of diagnostic lab testing, including for rabies, monkeypox, and other infectious diseases. This move comes amid an ongoing evaluation and restructuring process at the federal agency.

Why it matters

The CDC's lab testing capabilities are critical for identifying and tracking the spread of infectious diseases. The suspension of these tests could impact public health monitoring and response efforts, especially for emerging threats like monkeypox.

The details

The CDC has not provided a full list of the specific tests that have been paused, but the agency confirmed the temporary suspension is part of an ongoing evaluation and downsizing process. The goal is to streamline operations and focus resources on the agency's top priorities.

  • The testing pauses began in early 2026.

The players

Centers for Disease Control and Prevention (CDC)

The leading national public health institute in the United States, responsible for protecting public health and safety through the control and prevention of disease, injury, and disability.

Got photos? Submit your photos here. ›

What’s next

The CDC has not provided a timeline for when the suspended tests may resume, stating the evaluation process is ongoing.

The takeaway

This move by the CDC highlights the challenges of maintaining comprehensive disease surveillance and testing capabilities, especially during periods of organizational change and resource constraints.